The 7 analysts offering 12-month price forecasts for Novocure Ltd have a median target of 84.00, with a high estimate of 125.00 and a low estimate of 73.00. The median estimate represents a -24.00% decrease from the last price of 110.53.
The current consensus among 8 polled investment analysts is to Hold stock in Novocure Ltd. This rating has held steady since September, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.05
Reporting Date Oct 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.